case_images: PMC11800540_01
case_images: (A, B) Chest CT on April 12, 2024, shows enlarged right hilar lymph nodes, measuring approximately 21.63 mm x 21.14 mm. (C, D) Chest CT on April 20, 2024, shows enlarged right hilar lymph nodes, measuring approximately 22.80 mm x 22.75 mm. (E, F) Chest CT on April 25, 2024, shows enlarged right hilar lymph nodes, measuring approximately 31.66 mm x 23.85 mm, with thickening of the interlobular septa in the right upper lung. (G, H) Chest CT on April 29, 2024, shows enlarged right hilar lymph nodes, measuring approximately 32.75 mm x 21.64 mm, with thickening of the interlobular septa in the right upper lung. (I, J) Chest CT on September 25, 2024, showed significant absorption of the pulmonary lesions after antituberculosis treatment, and the hilar lymph nodes had decreased in size, measuring approximately 25.19 mm x 15.68 mm
case_images: 12890_2025_3539_Fig2_HTML.jpg
case_images: PMC11800540_01_12890_2025_3539_Fig2_HTML.jpg
case_images: Fig2
case_images: During his treatment period (from April 10 to April 25, 2024), chest CT scans indicated progressive enlargement of the right hilar lymph nodes and newly developed thickening of the interlobular septa in the right upper lobe (Fig. 2A and F). T-SPOT result of > 12.00 pg/ml . The chest contrast enhanced CT scan shows that the lymph node has slightly enlarged compared to April 25, 2024 (Fig. 2G and H). The chest CT showed significant absorption of the pulmonary lesions, and the hilar lymphadenopathy had also reduced (Fig. 2I and J).
case_images: Pathological result: necrotizing granuloma
case_images: 12890_2025_3539_Fig3_HTML.jpg
case_images: PMC11800540_01_12890_2025_3539_Fig3_HTML.jpg
case_images: Fig3
case_images: Subsequently, Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed to obtain lymph node tissue, and the pathology results indicated necrotizing granuloma (Fig. 3).